MoleculeMind reports its AI design platform found confirmed binders in 18 of 19 campaigns, including six GPCR targets
The Shanghai company's technical report covers nanobodies and macrocyclic peptides against 18 targets, with 139 confirmed binders from 453 tested candidates (30.7%); the results are the company's own and not peer reviewed.